Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Mitochondrial-associated Mechanisms of Neuropathological…

U.S. National Institutes of Health·United States of America

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)

Closes 3/10/2026$200k – $2.5MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is promoting research investigating protective and pathogenic mechanisms at the nexus of mitochondria function and aging in the context of HIV infection and exposure to addictive substances. This foundational knowledge could be leveraged to develop targeted therapies and improve outcomes in people aging with HIV, substance use, and addiction. The opportunity is open to various applicant types, including public and state-controlled institutions of higher education, city or township governments, and non-profits. The expected application count is 100, and the application size is not specified. • The opportunity number is RFA-DA-26-009. • The opening date is February 10, 2025, and the closing date is March 10, 2026. • The opportunity is for a grant, and the award ceiling and floor are not specified. • The applicant eligibility includes other eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, and eligible agencies of the federal government.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
9/30/2024
Closes
3/10/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-DA-26-009

Budget estimate

$200,000 – $2,500,000

The budget amount for this grant is not explicitly stated in the document, but based on the NIH's typical funding ranges for research grants, it could be estimated to be between $200,000 to $500,000 per year for a period of 2-5 years. The actual budget amount will depend on the specific proposal, the applicant's qualifications, and the NIH's funding priorities. Factors that may influence the likely payment range include the scope of the project, the number of personnel involved, and the duration of the grant.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 70%

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

70% match

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Closes 10/28/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

67% match

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Closes 6/7/2027Opened 8/20/2026

U.S. National Institutes of Health·United States of America

67% match

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

Closes 5/7/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

66% match

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/22/2025

U.S. National Institutes of Health·United States of America

66% match

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

Closes 5/7/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

64% match

Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/20/2026

U.S. National Institutes of Health·United States of America

64% match

HIV/AIDS Clinical Trials Network Leadership and Operations Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

64% match

HIV/AIDS Clinical Trials Network Statistical and Data Management Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

64% match

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Closes 11/9/2026Opened 2/12/2026

U.S. National Institutes of Health·United States of America

64% match

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

64% match

HIV/AIDS Clinical Trials Network Clinical Trials Units

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

64% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

64% match

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)

Closes 10/20/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

64% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

64% match

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. National Institutes of Health·United States of America

63% match

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Closes 11/8/2027Opened 5/22/2025

U.S. National Institutes of Health·United States of America

63% match

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 6/16/2023

U.S. National Institutes of Health·United States of America

63% match

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Closes 1/7/2028Opened 10/28/2024

U.S. National Institutes of Health·United States of America

63% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

U.S. National Institutes of Health·United States of America

63% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

63% match

Establishing a Research Network to Guide Foundational Research on Human Consciousness

Closes 2/7/2027Opened 4/28/2026

U.S. National Institutes of Health·United States of America

63% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. Food and Drug Administration·United States of America

63% match

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

63% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026